Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Insys Theraptcs Cmn (NASDAQ: INSY)

$11.21 USD $0.70 (6.66%)
Last Price $11.21
Net Change $0.7 (6.66%)
Bid $10
Ask Price $11.22
Open Price $10.53
Previous Close Price $10.51
High Price $11.22
Low Price $10.53
Number of Trades 2,284
Volume 661,461
Fifty Two Week High $19.96 (2016-08-10)
Fifty Two Week Low $8.7 (2016-12-08)
Average Daily Volume 981,215
Share Outstanding 72,110 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $0.03 (2017-04-03)
2nd Quarter Earnings $0.07 (2016-11-03)
3nd Quarter Earnings $0.13 (2016-08-03)
4th Quarter Earnings $0.11 (2016-04-28)
PE Ratio $129.5
EPS Growth $-467.86
Recent Earnings $0.03
Annual EPS $0.08
Last Quarter EPS $
Market Capitalization $0.81B
Insider Shareholders % 0.692%
Annual Revenue $0B
No. Shares Outstanding 72,110
Inst. Shareholder % 41.35%
Annual Net Income $0B
TTM Net Profit Margin $101.78
1-Year Return -31.75%
3-Year Return -47.32%
5-Year Return 200.29%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -467.859985%
Dividends per Share $
Stock Split Ratio 2-1
Beta 0.7
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.